These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7083729)

  • 21. Arrhythmias and antiarrhythmic drugs.
    Bigger JT
    Adv Intern Med; 1972; 18():251-81. PubMed ID: 4576083
    [No Abstract]   [Full Text] [Related]  

  • 22. Bretylium tosylate: profile of the only available class III antiarrhythmic agent.
    Anderson JL
    Clin Ther; 1985; 7(2):205-24. PubMed ID: 3886143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Propafenone for the treatment of severe ventricular arrhythmias.
    Rabkin SW; Rotem CE; Boroomand-Rashti K; Bar-Shlomo B
    Can Med Assoc J; 1984 Sep; 131(6):601-3. PubMed ID: 6478345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS; Zehender M
    Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiarrhythmic effect related to the plasma concentration of pentisomide in vivo and the antiarrhythmic-concentration relationship in vitro.
    Hachisu M; Chen H; Soneda T; Fujishima K; Ishizuka T; Konno F
    Drugs Exp Clin Res; 1995; 21(4):145-51. PubMed ID: 8529527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electrophysiologic actions of UM-272 (Pranolium) on reentrant ventricular arrhythmias in postinfarction canine myocardium.
    Gibson JK; Lucchesi BR
    J Pharmacol Exp Ther; 1980 Aug; 214(2):347-53. PubMed ID: 7391982
    [No Abstract]   [Full Text] [Related]  

  • 27. [Comparative effectiveness of the beta-(N,N-diethylamino)ethylamide hydrochloride of fusaric acid, obzidan and atenolol in experimental adrenaline-induced cardiac arrhythmia].
    Savina MD
    Farmakol Toksikol; 1986; 49(3):47-50. PubMed ID: 3720934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disposition of pranolium chloride in dogs, baboons and monkeys.
    Allan L; Barrow A; Haskins NJ; Rogers M; Rose DA; Palmer RF
    Eur J Drug Metab Pharmacokinet; 1981; 6(3):179-87. PubMed ID: 7308238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of ivabradine and beta-blocker therapy on dobutamine-induced ventricular arrhythmias.
    Mert KU; Mert GÖ; Morrad B; Tahmazov S; Mutlu F; Çavuşoglu Y
    Kardiol Pol; 2017; 75(8):786-793. PubMed ID: 28541596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MS-551 and KCB-328, two class III drugs aggravated adrenaline-induced arrhythmias.
    Xue Y; Yamada C; Aye NN; Hashimoto K
    Br J Pharmacol; 1998 Aug; 124(8):1712-8. PubMed ID: 9756388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antiarrhythmic activity of adrenergic blockaders with different mechanisms of action].
    Gendenshteĭn EI; Kostin IaV; Volkova ND
    Kardiologiia; 1977 Apr; 17(4):116-20. PubMed ID: 196133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiarrhythmic therapy for the elderly: a two-edged sword.
    Mehlman DJ; Arnsdorf MF
    Geriatrics; 1979 May; 34(5):29-33, 38-9, 42-9 passim. PubMed ID: 374183
    [No Abstract]   [Full Text] [Related]  

  • 33. [Electrophysiologic and anti-arrhythmia properties of propafenone deducible from experimental studies in vitro].
    Ledda F; Mantelli L
    G Ital Cardiol; 1984 Apr; 14(4):279-84. PubMed ID: 6329868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sotalol: a breakthrough antiarrhythmic?
    Nappi JM; McCollam PL
    Ann Pharmacother; 1993 Nov; 27(11):1359-68. PubMed ID: 8286812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiarrhythmic effects of four different beta-adrenergic blockers in the mouse chloroform arrhythmia model.
    Reynolds RD; Calzadilla SV
    Res Commun Chem Pathol Pharmacol; 1980 Aug; 29(2):361-4. PubMed ID: 6106265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Esmolol prevents and suppresses arrhythmias during halothane anaesthesia in dogs.
    Dimich I; Lingham R; Narang J; Sampson I; Shiang H
    Can J Anaesth; 1992 Jan; 39(1):83-6. PubMed ID: 1346371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of (plus or minus)-propranolol, (plus or minus)-,(plus)-, and (minus)-alprenolol on unanaesthetized dogs with ventricular arrhythmias resulting from coronary artery ligation.
    Duce BR; Garberg L; Smith ER
    Br J Pharmacol; 1970 Aug; 39(4):809-16. PubMed ID: 4394971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental evaluation of antiarrhythmic drugs in the guinea pig.
    Giudicelli JF; Witchitz S; Larno S; Boissier JR
    Biomedicine; 1973 Jul; 19(7):308-13. PubMed ID: 4783987
    [No Abstract]   [Full Text] [Related]  

  • 39. The clinical pharmacology and therapeutic applications of the antiarrhythmic drugs.
    Mason DT; Spann JF; Zelis R; Amsterdam EA
    Clin Pharmacol Ther; 1970; 11(4):460-80. PubMed ID: 4913865
    [No Abstract]   [Full Text] [Related]  

  • 40. Do antiarrhythmic drugs work? Some reflections on the implications of the Cardiac Arrhythmia Suppression Trial.
    Singh BN
    Clin Cardiol; 1990 Oct; 13(10):725-8. PubMed ID: 2257714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.